8-K
filed May 29, 2026, 4:13 PM ET
ticker ENVB
CIK 0000890821
other material
confidence high
sentiment neutral
materiality 0.65
Enveric shareholders approve reverse stock split, reject increase in authorized shares
Enveric Biosciences, Inc.
- Reverse stock split (1:5 to 1:15) approved: 793,344 for, 190,175 against, 8,309 abstentions.
- Authorized share increase to 5B shares rejected: 427,158 for, 555,147 against, 9,523 abstentions.
- Six director nominees elected: Michael Webb, George Kegler, Frank Pasqualone, Marcus Schabacker, Joseph Tucker, Sheila DeWitt.
- Say-on-pay advisory vote passed: 569,552 for, 26,884 against, 5,297 abstentions.
- Ratification of CBIZ CPAs as auditor passed: 960,728 for, 19,347 against, 11,753 abstentions.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Enveric Biosciences, Inc. shareholders approved Say-on-Pay Proposal at the 2026-05-28 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
2. The votes cast on the advisory vote for the Say-on-Pay Proposal were as follows: Votes Against Abstentions Broker Non-Votes 569,552 26,884 5,297 390,095
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Enveric Biosciences, Inc. shareholders approved Ratification of appointment of CBIZ CPAs P.C. as independent auditor at the 2026-05-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
5. The votes cast on the Auditor Ratification Proposal were as follows: Votes Against Abstentions 960,728 19,347 11,753
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Enveric Biosciences, Inc. shareholders approved Election of Directors at the 2026-05-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
1. The votes cast on the Election of Directors were as follows: Nominee Votes For Withheld Broker Non-Votes Michael Webb 564,143 37,590 390,095 George Kegler 531,522 70,211 390,095 Frank Pasqualone 531,937 69,796 390,095 Marcus Schabacker, M.D., Ph.D. 566,038 35,695 390,095 Joseph Tucker, Ph.D. 565,386 36,347 390,095 Sheila DeWitt, Ph.D 565,534 36,199 390,095
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Enveric Biosciences, Inc. shareholders rejected Authorized Stock Increase Proposal at the 2026-05-28 meeting.
- Proposal
- charter amendment
- Outcome
- failed
- Meeting
- 2026-05-28
Exact text from the filing
4. The votes cast on the Authorized Stock Increase Proposal were as follows: Votes Against Abstentions 427,158 555,147 9,523
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.95
Enveric Biosciences, Inc. shareholders approved Reverse Stock Split Proposal at the 2026-05-28 meeting.
- Proposal
- reverse split
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
3. The votes cast on the Reverse Stock Split Proposal were as follows: Votes Against Abstentions 793,344 190,175 8,309
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.